making muscle wasting history

PTC Completes Enrollment of Ataluren Study in Nonsense Mutation DMD

• Last Edited: 5 May 2009
• Permanent link

PTC Therapeutics has completed patient enrollment of a pivotal clinical trial of ataluren in patients with nonsense mutation Duchenne and Becker muscular dystrophy (nmDMD/BMD) two months ahead of ...

Tags: ataluren, nonsense mutation, PTC124, PTC Therapeutics.

Update on Ataluren Data Presented at the International Congress on Neuromuscular Diseases

• Last Edited: 2 Aug 2010
• Permanent link

PTC Therapeutics, Inc.July 30, 2010Update on Ataluren Data Presented at the International Congress on Neuromuscular DiseasesOn July 20, additional analyses of efficacy results from the Phase 2b cl...

Tags: Ataluren, PTC Therapeutics.